Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
STAT Research, Inc.
66
mi
from 43215
Dayton, OH
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
STAT Research, Inc.
66
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Arthritis & Rheumatology Center Of Oklahoma Pllc
849
mi
from 43215
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Arthritis & Rheumatology Center Of Oklahoma Pllc
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Lynn Health Science Institute
849
mi
from 43215
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Lynn Health Science Institute
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
OMRF
849
mi
from 43215
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
OMRF
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
UTMB Pathology Clinical Services
993
mi
from 43215
Galveston, TX
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
UTMB Pathology Clinical Services
993
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Arthritis & Osteoporosis Clinic
980
mi
from 43215
Waco, TX
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Arthritis & Osteoporosis Clinic
980
mi
from 43215
Waco, TX
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Danville Orthopedic Clinic, Inc.
304
mi
from 43215
Danville, VA
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Danville Orthopedic Clinic, Inc.
304
mi
from 43215
Danville, VA
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Ohio State University Medical Center
0
mi
from 43215
Columbus, OH
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Ohio State University Medical Center
0
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Clinical Research Center of Reading, LLC
373
mi
from 43215
Wyomissing, PA
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Clinical Research Center of Reading, LLC
373
mi
from 43215
Wyomissing, PA
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
APRILLUS
5386
mi
from 43215
Ciudad Autonoma Buenos aires,
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
APRILLUS
5386
mi
from 43215
Ciudad Autonoma Buenos aires,
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Center for Rheumatology, Immunology and Arthritis
970
mi
from 43215
Fort Lauderdale, FL
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Center for Rheumatology, Immunology and Arthritis
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Anniston Medical Clinic, PC
462
mi
from 43215
Anniston, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Anniston Medical Clinic, PC
462
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Pinnacle Research Group, LLC
461
mi
from 43215
Anniston, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Pinnacle Research Group, LLC
461
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Achieve Clinical Research
497
mi
from 43215
Birmingham, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Achieve Clinical Research
497
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Med Investigations
2031
mi
from 43215
Fair Oaks, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Med Investigations
2031
mi
from 43215
Fair Oaks, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Premier Clinical Research, LLC
1972
mi
from 43215
Lakewood, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Premier Clinical Research, LLC
1972
mi
from 43215
Lakewood, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Novo Research, Inc.
1976
mi
from 43215
Long Beach, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Novo Research, Inc.
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
St. Mary Medical Center
1977
mi
from 43215
Long Beach, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
St. Mary Medical Center
1977
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Wallace Rheumatic Study Center
1978
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Wallace Rheumatic Study Center
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Division of Rheumatology
1982
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Division of Rheumatology
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Rheumatology Clinical Research Center
1982
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Rheumatology Clinical Research Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Ronald Reagan UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Ronald Reagan UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Inland Rheumatology and Osteoporosis Medical Group
1940
mi
from 43215
Upland, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Inland Rheumatology and Osteoporosis Medical Group
1940
mi
from 43215
Upland, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Inland Rheumatology Clinical Trials, Inc.
1939
mi
from 43215
Upland, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Inland Rheumatology Clinical Trials, Inc.
1939
mi
from 43215
Upland, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Asthma, Allergy, Arthritis and Lung Center
752
mi
from 43215
Daytona Beach, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Asthma, Allergy, Arthritis and Lung Center
752
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Arthritis Center
713
mi
from 43215
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Arthritis Center
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Community Pharmacy
713
mi
from 43215
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Community Pharmacy
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Integrated Medical, PL d/b/a Florida Medical Research Institute
713
mi
from 43215
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Integrated Medical, PL d/b/a Florida Medical Research Institute
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern lmaging & Diagnostics
713
mi
from 43215
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern lmaging & Diagnostics
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
New Horizon Research Center
996
mi
from 43215
Miami, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
New Horizon Research Center
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Arthritis Associates
795
mi
from 43215
Orlando, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Arthritis Associates
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Millennium Research
746
mi
from 43215
Ormond Beach, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Millennium Research
746
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
The Arthritis Center
821
mi
from 43215
Palm Harbor, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
The Arthritis Center
821
mi
from 43215
Palm Harbor, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Advent Clinical Research Centers
838
mi
from 43215
Pinellas Park, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Advent Clinical Research Centers
838
mi
from 43215
Pinellas Park, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Burnette & Silverfield MDs, PLC
825
mi
from 43215
Tampa, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Burnette & Silverfield MDs, PLC
825
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Emory University
435
mi
from 43215
Atlanta, GA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Grady Health Systems
435
mi
from 43215
Atlanta, GA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Grady Health Systems
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Idaho Arthritis Center
1725
mi
from 43215
Meridian, ID
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Idaho Arthritis Center
1725
mi
from 43215
Meridian, ID
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Beacon Medical Group Rheumatology
203
mi
from 43215
Granger, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Beacon Medical Group Rheumatology
203
mi
from 43215
Granger, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Indiana CTSI Clinical Research Center
166
mi
from 43215
Indianapolis, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Indiana CTSI Clinical Research Center
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Investigational Drug Services
166
mi
from 43215
Indianapolis, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Investigational Drug Services
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins University School of Medicine
345
mi
from 43215
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins University School of Medicine
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins Outpatient Center
345
mi
from 43215
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins Outpatient Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins Outpatient Express Testing Center
344
mi
from 43215
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins Outpatient Express Testing Center
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials